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participate.Angina Pectoris and Myocardial Ischemia in the Absence of Obstructive Coronary
Artery Disease: Practical Considerations for Diagnostic Tests453Francesco Radico, Vincenzo Cicchitti, Marco Zimarino, Raffaele De Caterina
Angina and myocardial ischemia without obstructive coronary artery disease are
common, and often neglected for the assumption of a good prognosis. However,
the absence of signiﬁcant coronary stenoses on angiography does not imply
a “healthy” coronary tree. In such cases, myocardial ischemia may result from
functional disease involving the epicardial coronary arteries, the coronary micro-
circulation, or both. An accurate assessment of these components should be
systematically performed because a correct diagnosis has relevant prognostic and
therapeutic implications. The authors discuss the basic principles of diagnostic
tests and propose a diagnostic sequence of reasonable practical implementation in
this setting.
JACC: Cardiovascular Interventions CME is available online.
Go to http://interventions.onlinejacc.org/ to participate.CORONARY
INTERVENTIONS
Clinical ResearchPredicting 3-Year Mortality After Percutaneous Coronary Intervention: Updated
Logistic Clinical SYNTAX Score Based on Patient-Level Data From 7 Contemporary
Stent Trials464Javaid Iqbal, Yvonne Vergouwe, Christos V. Bourantas, David V. Klaveren, Yao-Jun Zhang,
Carlos M. Campos, Hector M. García-García, Marie-Angele Morel, Marco Valgimigli,
Stephan Windecker, Ewout W. Steyerberg, Patrick W. Serruys
The Logistic Clinical SYNTAX score has been shown to perform better than the
SYNTAX score in predicting 1-year outcomes after percutaneous coronary
intervention. Iqbal and colleagues updated this score to predict 3-year mortality.
Patient-level data (N ¼ 6,304) from 7 trials were analyzed. The overall risk and
the predictor effects in the Logistic Clinical SYNTAX score were revised using
Cox regression analysis. They updated the core model (SYNTAX score, age,
creatinine clearance, and ejection fraction) and developed an extended model by
combining the core model with additional independent predictors of 3-year
mortality. The revised Logistic Clinical SYNTAX score outperformed the
SYNTAX score in predicting long-term mortality.
See additional content in the online version of this issue.(continued on A-25)
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A-25Everolimus-Eluting Xience V/Promus Versus Zotarolimus-Eluting Resolute Stents
in Patients With Diabetes Mellitus471Kyung Woo Park, Joo Myung Lee, Si-Hyuck Kang, Hyo-Suk Ahn, Hyun-Jae Kang,
Bon-Kwon Koo, Jay Young Rhew, Sun Ho Hwang, Sung Yoon Lee, Tae Soo Kang,
Choong Hwan Kwak, Bum-Kee Hong, Cheol Woong Yu, In-Whan Seong, Taehoon Ahn,
Han Cheol Lee, Sang Wook Lim, Hyo-Soo Kim
A total of 1,855 patients with diabetes mellitus (DM) treated with everolimus-
eluting stents (EES) versus Resolute zotarolimus-eluting stents (ZES) were
compared in terms of patient- and stent-related outcomes. Both target lesion failure
and patient-oriented composite events were similar between the EES and ZES
groups in the patients with DM at 1 year. Both stents also showed comparable
outcomes in nondiabetic patients. After unrestricted use of second-generation drug-
eluting stents in all-comers receiving percutaneous coronary intervention, both
EES and ZES showed comparable clinical outcomes in the patients with DM up to
1 year of follow-up. Overall incidences of target lesion failure were low, even in the
patients with DM, suggesting excellent safety and efﬁcacy of both types of second-
generation drug-eluting stents in this high-risk subgroup of patients.
See additional content in the online version of this issue.1-Year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting
Bioresorbable Vascular Scaffolds: A Pooled Analysis of the ABSORB and the
SPIRIT Trials482Takashi Muramatsu, Yoshinobu Onuma, Robert-Jan van Geuns, Bernard Chevalier,
Tejas M. Patel, Ashok Seth, Roberto Diletti, Hector M. García-García, Cécile C. Dorange,
Susan Veldhof, Wai-Fung Cheong, Yukio Ozaki, Robert Whitbourn, Antonio Bartorelli,
Gregg W. Stone, Alexandre Abizaid, Patrick W. Serruys, on behalf of the ABSORB Cohort B,
the ABSORB EXTEND, and the SPIRIT FIRST, II, III, and IV Investigators
Clinical outcomes of diabetic patients after ABSORB bioresorbable vascular scaffold
(BVS) implantation have been unreported. A total of 136 diabetic patients were
compared with 415 nondiabetic patients in pooled data from the ABSORB Cohort B
and ABSORB EXTEND trials. Diabetic patients treated with everolimus-eluting
metal stents (EES) from the SPIRIT trials (SPIRIT FIRST [A Clinical Trial of
the Abbott Vascular XIENCE V Everolimus Eluting Coronary Stent System],
SPIRIT II [A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary
Stent System], SPIRIT III [Clinical Trial of the XIENCE V Everolimus Eluting
Coronary Stent System (EECSS)], SPIRIT IV Clinical Trial [Clinical Evaluation of
the XIENCE V Everolimus Eluting Coronary Stent System]) were also used for the
comparison by applying propensity score matching. In the present analyses, diabetic
patients treated with the BVS showed a similar incidence of device-oriented
composite endpoints (DoCE) compared with nondiabetic patients treated with BVS
and diabetic patients treated with EES at 1-year follow-up.
See additional content in the online version of this issue.EDITORIAL COMMENTSecond-Generation Drug-Eluting Stents and Bioresorbable Vascular Scaffolds in
Patients With Diabetes494Mikkel M. Schoos, Peter Clemmensen, George D. Dangas(continued on A-26)
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A-26Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention
With First-Generation Drug-Eluting Stents: A Meta-Analysis of Randomized
Controlled Trials497Juwairia Al Ali, Caroline Franck, Kristian B. Filion, Mark J. Eisenberg
The efﬁcacy and safety of coronary artery bypass graft surgery (CABG) versus
percutaneous coronary intervention (PCI) with ﬁrst-generation drug-eluting stents
in patient subgroups remains controversial. The authors systematically searched
randomized controlled trials comparing the efﬁcacy of CABG versus PCI with
drug-eluting stents. Their results suggest that CABG is more efﬁcacious than PCI
with ﬁrst-generation drug-eluting stents in patients with left main disease and
multivessel disease, at the cost of increased rates of stroke. Data for patients with
single-vessel proximal left anterior descending disease were inconclusive.
See additional content in the online version of this issue.EDITORIAL COMMENTRevascularization Decisions in Coronary Artery Disease:
Hitting a Moving Target507Gregg W. StonePivotal Trial to Evaluate the Safety and Efﬁcacy of the Orbital Atherectomy
System in Treating De Novo, Severely Calciﬁed Coronary Lesions (ORBIT II)510Jeffrey W. Chambers, Robert L. Feldman, Stevan I. Himmelstein, Rohit Bhatheja,
Augusto E. Villa, Neil E. Strickman, Richard A. Shlofmitz, Daniel D. Dulas, Dinesh Arab,
Puneet K. Khanna, Arthur C. Lee, Magdi G. H. Ghali, Rakesh R. Shah, Thomas P. Davis,
Christopher Y. Kim, Zaheed Tai, Kirit C. Patel, Joseph A. Puma, Prakash Makam,
Barry D. Bertolet, Georges Y. Nseir
The ORBIT II (Evaluate the Safety and Efﬁcacy of OAS in Treating Severely
Calciﬁed Coronary Lesions) trial (May 25, 2010, to November 26, 2012) eval-
uated the safety and efﬁcacy of the coronary Orbital Atherectomy System (OAS)
to prepare de novo, severely calciﬁed coronary lesions for stent placement.
Investigators used the centrifugal action of the OAS diamond-coated crown to
modify calciﬁed lesions prior to stent placement. The ORBIT II coronary OAS
trial met both the primary safety and efﬁcacy endpoints by signiﬁcant margins.
Preparation of severely calciﬁed plaque with the OAS not only helped facilitate
stent delivery, but it also improved both acute and 30-day clinical outcomes
compared with those of historic control subjects in this difﬁcult-to-treat patient
population.EDITORIAL COMMENTAfter 3 Decades, at Long Last, a New Device to Deal With Calciﬁc Lesions 519Antonio Colombo, Vasileios F. Panoulas(continued on A-27)
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A-27STRUCTURAL
Clinical ResearchThe Learning Curve in Percutaneous Repair of Paravalvular Prosthetic
Regurgitation: An Analysis of 200 Cases521Paul Sorajja, Allison K. Cabalka, Donald J. Hagler, Charanjit S. Rihal
Sorajja et al. examined 200 patients who underwent percutaneous repair of para-
valvular prosthetic regurgitation by assigning a sequence number as a continuous
variable. Successful device delivery occurred in 92% with a procedural time of
139  47 min and 30-day major adverse cardiovascular event (MACE) rate of 7%.
With increased experience and adoption of dedicated imaging and catheter tech-
niques, there were decreases in procedural and ﬂuoroscopy time, contrast volume,
length of hospital stay, and MACE. Procedural success remained unchanged. The
predominant reason for failure was leaﬂet impingement. In summary, there was
a learning curve that occurred with adoption of dedicated catheter and imaging
techniques. Prosthetic leaﬂet impingement is the predominant procedural limitation.Effects of Transcatheter Pulmonary Valve Replacement on the Hemodynamic
and Ventricular Response to Exercise in Patients With Obstructed Right
Ventricle-to-Pulmonary Artery Conduits530Babar S. Hasan, Fatima I. Lunze, Ming Hui Chen, David W. Brown, Matthew J. Boudreau,
Jonathan Rhodes, Doff B. McElhinney
Evaluation of congenital heart disease patients with dysfunctional right ventricular
outﬂow tract conduits at rest may not be adequate for assessing the suitability and
timing of transcatheter pulmonary valve replacement (TPVR). Patients in the
cohort had high conduit gradients and decreased resting and peak exercise right
ventricular functional measures. These improved signiﬁcantly after TPVR. The
ability to augment right ventricular function at peak exercise before TPVR was
associated with improved exercise capacity 6 months after TPVR. Assessing right
ventricular outﬂow tract conduits and right ventricular function in these patients
using an exercise protocol may be beneﬁcial. Exercise-induced changes may help to
identify patients in need of TPVR who will beneﬁt the most from this intervention.
See additional content in the online version of this issue.PERIPHERAL
Clinical ResearchValidity of Estimated Glomerular Filtration Rates for Assessment of Renal Function
After Renal Artery Stenting in Patients With Atherosclerotic Renal Artery Stenosis543Geoffrey M. Crimmins, Ryan D. Madder, Victor Marinescu, Robert D. Saﬁan
Estimates of glomerular ﬁltration rate (eGFR) have not been validated for serial renal
function after renal artery stenting. Serum creatinine and 125I-iothalamate glomer-
ular ﬁltration rate (iGFR) were measured in 84 patients. eGFR was calculated using
Modiﬁcation of Diet in Renal Disease, Chronic Kidney Disease Epidemiology
Collaboration, and Cockcroft-Gault formulas. The sensitivity, speciﬁcity, and area
under the receiver-operating characteristic curve were determined for changes in
GFR before and after intervention, using iGFR as the standard. All eGFR
demonstrate poor reliability for detecting meaningful changes in GFR after stenting,
and should be abandoned as primary endpoints in renal stent trials.(continued on A-28)
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A-28MINI-FOCUS ISSUE:
RADIATION DOSE
REDUCTION
Clinical ResearchRadiation Dose Reduction in the Cardiac Catheterization Laboratory Utilizing
a Novel Protocol550Anthony W. A. Wassef, Brett Hiebert, Amir Ravandi, John Ducas, Kunal Minhas,
Minh Vo, Malek Kass, Gurpreet Parmar, Farrukh Hussain
Wassef et al. report the results of a novel radiation reduction protocol (RRP) in
the cardiac catheterization laboratory. Diagnostic coronary angiograms and
percutaneous coronary interventions from a single laboratory were analyzed
before and after RRP implementation. A 48% dose reduction (1.07  0.05 Gy vs.
0.56  0.03 Gy, p < 0.0001) was obtained, a 35% reduction (0.70  0.05 Gy,
p < 0.0001) at 15 frames/s (FPS) and a 62% reduction (0.41  0.02 Gy, p < 0.001)
at 7.5 FPS with no reduction in laboratory throughput. Using a multivariable model,
a 48% dose reduction with RRP (p < 0.001), 44% with 15 FPS RRP and 68% with
7.5 FPS RRP was obtained. This novel system needs strong consideration in
interventional cardiology practice.Relationship of Beam Angulation and Radiation Exposure in the Cardiac
Catheterization Laboratory558Shikhar Agarwal, Akhil Parashar, Navkaranbir Singh Bajaj, Imran Khan,
Imran Ahmad, Fredrick A. Heupler, Jr, Matthew Bunte, Dhruv K. Modi,
E. Murat Tuzcu, Samir R. Kapadia
Radiation scatter is poorly characterized in the context of catheterization labora-
tories using modern digital equipment. Agarwal et al. aimed to study the rela-
tionship between beam angulation and air kerma using a large database of sequences
derived from diagnostic catheterizations and percutaneous coronary interventions.
They observed that extreme angulations were associated with high air kerma values.
Fluoroscopy compared with acquisition (cine) was more sensitive to changes in
angulation, with relatively larger increases in total air kerma with small increases in
steepness of the angulation. The authors recommend minimizing the use of extreme
angulations whenever possible to reduce both patient and staff exposure.
See additional content in the online version of this issue.This article has accompanying videos that can be viewed in the online version
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A-29Effectiveness of Low Rate Fluoroscopy at Reducing Operator and Patient Radiation
Dose During Transradial Coronary Angiography and Interventions567Eltigani Abdelaal, Guillaume Plourde, Jimmy MacHaalany, Jean Arsenault, Goran Rimac,
Jean-Pierre Déry, Gérald Barbeau, Eric Larose, Robert De Larochellière, Can M. Nguyen,
Ricardo Allende, Henrique Ribeiro, Olivier Costerousse, Rosaire Mongrain, Olivier F. Bertrand,
for the Interventional Cardiologists at Quebec Heart-Lung Institute
Abdelaal et al. performed a randomized study to compare the efﬁcacy of low rate
ﬂuoroscopy at 7.5 frames/s (FPS) versus conventional 15 FPS for reduction of
operator and patient radiation dose during diagnostic coronary angiography
(DCA) and percutaneous coronary intervention (PCI) via the transradial approach.
Fluoroscopy at 7.5 FPS, compared with 15 FPS, was associated with 30% relative
reduction in operator dose and 19% relative reduction in patient’s dose-area
product. Fluoroscopy at 7.5 FPS was also associated with 26% reduction in
patient’s dose-area product during DCA and 19% during PCI. Fluoroscopy at 7.5
FPS, compared with 15 FPS, is a simple and effective method in reducing operator
and patient radiation dose during transradial approach DCA and PCI.IMAGES IN
INTERVENTIONSerial 2-Dimensional and 3-Dimensional Optical Coherence Tomography
Assessment of Overhanging Struts of Drug-Eluting Absorbable Metal Scaffold:
“DREAMS” for Jailed Side Branch?575Takashi Muramatsu, Hector M. García-García, Patrick W. Serruys, Ron Waksman,
Stefan Verheye, on behalf of the BIOSOLVE-I InvestigatorsUnintentional “Ventriculo-Phlebo-Myo-Pericardiography” 577Olivier Gach, Mathieu Lempereur, Eric Eeckhout, Victor Legrand
This article has accompanying videos that can be viewed in the online version
of this issue.(continued on A-30)
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A-30In-Stent Protrusion After Implantation of a Drug-Eluting Stent
in a Honeycomb-Like Coronary Artery Structure: Complete Resolution Over 6
Months and the Role of Optical Coherence Tomography Imaging in the Diagnosis
and Follow-Upe39Kohei Koyama, Kihei Yoneyama, Takanobu Mitarai, Shingo Kuwata, Yuki Ishibashi,
Ken Kongoji, Yoshihiro J. AkashiNoncardiac Pathology Exposed at Coronary Angiography for
ST-Segment Elevatione41Jennifer A. Rossington, Matthew Balerdi, Angela J. HoyeFeasibility and Efﬁcacy of Bioresorbable Vascular Scaffolds
Use for the Treatment of In-Stent Restenosis and a Bifurcation Lesion in a Heavily
Calciﬁed Diffusely Diseased Vessele45Toru Naganuma, Charis Costopoulos, Azeem Latib, Katsumasa Sato, Tadashi Miyazaki,
Antonio ColomboAnatomic Stabilization and Functional Normalization of
a Ruptured Coronary Plaque 12 Months After Implantation of a Bioresorbable
Scaffolde47Tommaso Gori, Eberhard Schulz, Thomas Münzel
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